Strongyloidiasis overview: Difference between revisions
Created page with "__NOTOC__ {{Strongyloidiasis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{Re..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Strongyloidiasis}} | {{Strongyloidiasis}} | ||
{{CMG}} | |||
==Overview== | |||
'''Strongyloidiasis''' is a [[List of human parasitic diseases|human parasitic disease]] caused by the [[nematode]] (roundworm) ''[[Strongyloides stercoralis]]'', or sometimes ''S. fülleborni''. It can cause a number of symptoms in people, principally skin symptoms, [[abdominal pain]], [[diarrhea]] and [[weight loss#Unintentional weight loss|weight loss]]. In some people, particularly those who require [[corticosteroid]]s or other immunosuppressive medication, ''Strongyloides'' can cause a '''hyperinfection syndrome''' that can lead to death if untreated. The diagnosis is made by blood and stool tests. The drug [[ivermectin]] is widely used in the treatment of strongyloidiasis. | |||
It is thought to affect 30–100 million people worldwide, mainly in tropical and subtropical countries. Worldwide efforts are aimed at eradicating the infection in high-risk groups. Strongyloidiasis was first described in France in 1876. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
Revision as of 15:17, 10 December 2012
|
Strongyloidiasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Strongyloidiasis overview On the Web |
|
American Roentgen Ray Society Images of Strongyloidiasis overview |
|
Risk calculators and risk factors for Strongyloidiasis overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Strongyloidiasis is a human parasitic disease caused by the nematode (roundworm) Strongyloides stercoralis, or sometimes S. fülleborni. It can cause a number of symptoms in people, principally skin symptoms, abdominal pain, diarrhea and weight loss. In some people, particularly those who require corticosteroids or other immunosuppressive medication, Strongyloides can cause a hyperinfection syndrome that can lead to death if untreated. The diagnosis is made by blood and stool tests. The drug ivermectin is widely used in the treatment of strongyloidiasis.
It is thought to affect 30–100 million people worldwide, mainly in tropical and subtropical countries. Worldwide efforts are aimed at eradicating the infection in high-risk groups. Strongyloidiasis was first described in France in 1876.